MacroGenics, Inc. (MGNX)
1.79
+0.03
(+1.70%)
USD |
NASDAQ |
Jan 23, 15:41
MacroGenics Cash from Investing (Quarterly): -20.37M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Amicus Therapeutics, Inc. | -1.299M |
| Gilead Sciences, Inc. | -427.00M |
| CorMedix, Inc. | -291.32M |
| Xencor, Inc. | 14.67M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.19M |
| Free Cash Flow | -164.76M |
| Free Cash Flow Per Share (Quarterly) | -0.4837 |
| Free Cash Flow to Equity (Quarterly) | -30.37M |
| Free Cash Flow to Firm (Quarterly) | -27.27M |
| Free Cash Flow Yield | -146.1% |